Literature DB >> 17709590

Symptomatic interferon retinopathy successfully treated by hypertension management.

C Han, J O'Day.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17709590      PMCID： PMC1954887          DOI： 10.1136/bjo.2006.112532

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  IFN-alpha sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA.

Authors:  William J Kaiser; Jonathan L Kaufman; Margaret K Offermann
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

2.  Interferon-associated retinopathy in a uniform regimen of natural interferon-alpha therapy for chronic hepatitis C.

Authors:  H Saito; H Ebinuma; H Nagata; Y Inagaki; Y Saito; K Wakabayashi; T Takagi; M Nakamura; H Katsura; Y Oguchi; H Ishii
Journal:  Liver       Date:  2001-06

3.  Retinopathy associated with high-dose interferon alfa-2b therapy.

Authors:  C Hejny; P Sternberg; D H Lawson; K Greiner; T M Aaberg
Journal:  Am J Ophthalmol       Date:  2001-06       Impact factor: 5.258

4.  Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.

Authors:  Louis d'Alteroche; Samuel Majzoub; Anne-Isabelle Lecuyer; Marie-Paule Delplace; Yannick Bacq
Journal:  J Hepatol       Date:  2005-08-18       Impact factor: 25.083

5.  Interferon-associated retinopathy.

Authors:  D R Guyer; J Tiedeman; L A Yannuzzi; J S Slakter; D Parke; J Kelley; R A Tang; M Marmor; G Abrams; J W Miller
Journal:  Arch Ophthalmol       Date:  1993-03

6.  Retinal complications during interferon therapy for chronic hepatitis C.

Authors:  T Kawano; M Shigehira; H Uto; T Nakama; J Kato; K Hayashi; T Maruyama; T Kuribayashi; T Chuman; T Futami; H Tsubouchi
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864
  6 in total
  2 in total

1.  Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon alpha and ribavirin.

Authors:  Masako Murata; Yuu Tamura; Masaya Ohsawa; Takao Hirano; Toshihiko Matsuo; Toshinori Murata
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

Review 2.  Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Authors:  Roderick O'Day; Mark C Gillies; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.